Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 2 weeks ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 2 weeks agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 weeks agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi...
Benzinga· 2 weeks agoNovavax has a sole license to its adjuvanted COVID-19 vaccine for use in combination with Sanofi’s...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 2 weeks agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 2 weeks agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
France’s Sanofi in COVID-19 vaccine deal with Novavax
KFGO· 2 weeks agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 2 weeks agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 2 weeks agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 weeks agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...